The oral COVID-19 drug is the second to produce promising trial results.
Meet molnupiravir, Merck’s Thor-inspired pill that hammers COVID
In Phase III trial, the drug smashed hospitalization and death rate by about half.
The oral COVID-19 drug is the second to produce promising trial results.
In Phase III trial, the drug smashed hospitalization and death rate by about half.